U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06907238) titled 'The Value of Novel Thrombus Markers in the Diagnosis and Treatment of Acute Pulmonary Embolism' on March 26.
Brief Summary: In response to the high mortality rate of patients with acute pulmonary embolism (APE) and the fact that only a small proportion of deceased patients can receive correct diagnosis, this study will use a sensitive, non-invasive, and feasible new thrombus molecular marker (TAT/PIC/TM/t-PAIC) to detect and evaluate the activation of the coagulation and fibrinolysis systems and endothelial system damage in patients, in order to monitor the early diagnosis and treatment of APE, reduce mortality, and improve patient ...